XML 16 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net loss $ (4,773,907) $ (3,868,040)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation 2,008,801 1,661,558
Depreciation 402
Amortization 10,666 2,105
Non-cash lease expense 496 4,208
Gain on sale of short-term investments (92,915) (180,593)
Share of net income from equity method investment (4,651)
Changes in operating assets and liabilities:    
Accounts receivable (5,262) (9,608)
Accounts receivable - related party (540)
Prepaid assets 175,245 119,237
Inventory (1,955) (4,249)
Accounts payable - related party (260,000)
Accounts payable 7,008 (325,818)
Accrued expenses (128,437) 67,069
Lease liability (4,463) (37,625)
Net cash used in operating activities (2,809,914) (2,831,354)
Cash flows from investing activities:    
Sale of short-term investments 22,348,611 32,671,394
Purchase of short-term investments (24,399,610) (29,270,926)
Purchase of patents (101,936) (96,000)
Purchase of trademarks (52,144) (74,460)
Net cash provided by (used in) investing activities (2,205,079) 3,230,008
Cash flows from financing activities:    
Payments on notes payable - officer (200,000)
Issuance of common stock 4,516,184
Net cash provided by (used in) financing activities 4,516,184 (200,000)
Net increase (decrease) in cash and cash equivalents (498,809) 198,654
Cash and cash equivalents - beginning of period 580,230 162,743
Cash and cash equivalents - end of period 81,421 361,397
Non-cash investing and financing activities:    
Unrealized gain (loss) on short-term investments $ 80 $ (35,513)